Article Text
Statistics from Altmetric.com
We read with great interest the COVID-LT study by C Becchetti et al,1 which included 57 liver transplant (LT) patients from 12 European institutions who were diagnosed with coronavirus disease 2019 (COVID-19). Simultaneously, the Spanish Society of Liver Transplantation (SETH) has conducted a nationwide prospective study including 22 transplant institutions and 111 LT patients with COVID-19.2 Since there were only nine overlapped cases, both cohorts add up to 159 LT patients and taken together their close analysis (table 1) may derive in practical conclusions.
- In this window
- In a new window
The crude incidence of COVID-19 was increased in the SETH study as compared with the COVID-LT study (0.84% vs 0.48%), even with a shorter recruitment period. This could be explained because the SETH study was performed during the outbreak period in Spain, one of the toughest in Europe.3 The SETH study …